Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Identifying Regenerative Pathways Within the Molecular Mechanisms of Fusicoccane Compounds

FY 2019-20

Summary
"In the mature central nervous system, injured axons fail to regenerate, leading to persistent neurological deficits such as the case of paralysis following spinal cord injury. Neuroregenerative drug design has proven to be difficult due to the complex mixture of intracellular and extracellular factors contributing to the central nervous system's poor regenerative abilities. The Fournier lab has identified proregenerative properties for the small molecule Fusicoccin-A (FC-A). FC-A promotes regeneration by modulating multiple signaling pathways through its interaction with proteins known as 14-3-3s. 14-3-3s bind hundreds of client proteins to regulate their activity. Collaborators have provided us with a library of semi-synthetic FC-A analogues with varying regenerative potencies. Using mass spectrometry, we identified a list of approximately 500 14-3-3:client interactions modulated by FC-A. We have confirmed the proregenerative roles of a dozen of these interactions in vitro. In order to rationally select new interactions to investigate, we propose to perform mass spectrometry of 14-3-3:client complexes using our 3 most and 3 least potent fusicoccin analogues. By comparing the datasets between analogues, we expect to identify interactions specific to our most potent analogues. These interactions will then be tested in vitro using pharmacological and biochemical approaches. These results will provide insight into the cell biology of neuroregeneration, which may lead to the development of novel proregenerative drugs."
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
429027
Name
Simas Tristan
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identifying Regenerative Pathways Within the Molecular Mechanisms of Fusicoccane Compounds
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Cell Biology; Cell Signaling; Data Mining; Gene Ontology; High Content Screening; Neuropharmacology; Neuroregeneration; Polypharmacology; Systems Proteomics
Abstract
"In the mature central nervous system, injured axons fail to regenerate, leading to persistent neurological deficits such as the case of paralysis following spinal cord injury. Neuroregenerative drug design has proven to be difficult due to the complex mixture of intracellular and extracellular factors contributing to the central nervous system's poor regenerative abilities. The Fournier lab has identified proregenerative properties for the small molecule Fusicoccin-A (FC-A). FC-A promotes regeneration by modulating multiple signaling pathways through its interaction with proteins known as 14-3-3s. 14-3-3s bind hundreds of client proteins to regulate their activity. Collaborators have provided us with a library of semi-synthetic FC-A analogues with varying regenerative potencies. Using mass spectrometry, we identified a list of approximately 500 14-3-3:client interactions modulated by FC-A. We have confirmed the proregenerative roles of a dozen of these interactions in vitro. In order to rationally select new interactions to investigate, we propose to perform mass spectrometry of 14-3-3:client complexes using our 3 most and 3 least potent fusicoccin analogues. By comparing the datasets between analogues, we expect to identify interactions specific to our most potent analogues. These interactions will then be tested in vitro using pharmacological and biochemical approaches. These results will provide insight into the cell biology of neuroregeneration, which may lead to the development of novel proregenerative drugs."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Simas, Tristan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~